نتایج جستجو برای: immunoglobuling

تعداد نتایج: 14  

Journal: :international journal of pediatrics 0
enayatollah kalantar dietary supplements and probiotics research center, alborz university of medical sciences, karaj, iran. mohammad javad gharavi deputy of research affairs, alborz university of medical sciences, karaj, iran. mojgan oshaghi department of microbiology and immunology, school of paramedical sciences, iran university of medical sciences, tehran, iran. behnaz gharegozlou department of microbiology and immunology, school of paramedical sciences, iran university of medical sciences, tehran, iran. sara mohammadi deputy of research affairs, alborz university of medical sciences, karaj, iran. ramin heshmat epidemiology department, chronic diseases research center, endocrinology and metabolism population sciences institute, tehran university of medical sciences, tehran, iran.

background: helicobacter pylori (h.pylori) is a common bacterial infection, with considerably high morbidity and mortality worldwide. this bacterium represents a key factor in the etiology of various chronic infections ranging from gastritis, peptic ulcer disease to gastric cancer; but the prevalence has large variations in different communities. the aim of this study was to estimate the preval...

Journal: :Molecular Vision 2009
Hongshan Liu Winston W.Y. Kao

PURPOSE To develop a new method of whole mount immunostaining that improves the penetration of staining reagents into the cornea and decreases non-specific binding and background. METHODS Adult mouse corneas were fixed overnight in 4% paraformaldehyde or a mixture of 4% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, at 4 degrees C. After washing with 0.1% Triton X...

2016
Thomas G. Forsthuber Olaf Stuve

Laquinimod is an orally available quinoline 3carboxamide derivative drug studied in phase II and III clinical trials for relapsing-remitting multiple sclerosis (RRMS), systemic lupus erythematosus, and Crohn disease. Laquinimod has shown promise in RRMS clinical trials, and identifying the mechanism underlying its disease-modifying effects could help target it to the patient population where it...

Journal: :Neurology(R) neuroimmunology & neuroinflammation 2016
Thomas G Forsthuber Olaf Stuve

Laquinimod is an orally available quinoline 3carboxamide derivative drug studied in phase II and III clinical trials for relapsing-remitting multiple sclerosis (RRMS), systemic lupus erythematosus, and Crohn disease. Laquinimod has shown promise in RRMS clinical trials, and identifying the mechanism underlying its disease-modifying effects could help target it to the patient population where it...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید